Biologics Spine Kuros Biosciences USA, Inc. Announces an Exclusive Strategic Agreement with the Medtronic Spinal Division byJosh SandbergJanuary 7, 2025
Financial Medtronic to announce financial results for its second quarter of fiscal year 2025 byTim AllenNovember 5, 2024
Spine Medtronic expands AiBLE™ spine surgery ecosystem with new technologies and Siemens Healthineers partnership byJosh SandbergSeptember 25, 2024
Financial Medtronic announces cash dividend for second quarter of fiscal year 2025 byJosh SandbergAugust 16, 2024
Financial Top Stories Medtronic announces departure of Karen Parkhill, Chief Financial Officer byJosh SandbergJune 26, 2024
Regulatory Spine Medtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulator byTim AllenApril 26, 2024
Regulatory Top Stories U.S. Patent Office rejects Axonics’ latest challenge to Medtronic patents byTim AllenMarch 21, 2024
Financial Medtronic announces cash dividend for third quarter of fiscal year 2024 byJosh SandbergDecember 8, 2023
Spine SI-BONE, Inc. Announces iFuse Bedrock Granite® Implant System Compatibility with Certain Medtronic CD Horizon® Solera® 5.5/6.0 System Rods byJosh SandbergSeptember 5, 2023
